Philip Morris International (PM) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Achieved record first-half organic top-line and operating income growth, driven by strong performance in smoke-free products, especially IQOS and ZYN, across multiple regions, despite supply constraints and regulatory headwinds.
Diluted EPS increased 27.5% year-over-year to $2.92, with adjusted diluted EPS up 10.6% in Q2 excluding currency impacts, reflecting robust operating income and margin expansion.
Smoke-free products accounted for over 38% of net revenues, with 36.5 million adult users globally, and ZYN and IQOS leading growth.
Full-year guidance was raised for organic net revenue, operating income, and EPS, despite significant currency and regulatory headwinds.
Net cash from operating activities more than doubled to $4.9 billion, supported by improved working capital and higher earnings.
Financial highlights
Net revenues for H1 2024 rose 7.5% to $18.3 billion, with Q2 organic net revenue up 9.6% and shipment volume growth of 2.8%.
Adjusted diluted EPS for Q2 was $1.59, up 10.6% excluding currency, and H1 adjusted diluted EPS grew 16.8% in constant currency.
Operating income grew 22.5% to $6.5 billion in H1, with margin expansion supported by pricing, volume/mix, and lower impairment charges.
Gross margin increased to 64.2% for six months, up 1.1 percentage points year-over-year.
Net cash from operating activities for six months was $4.9 billion, up from $2.5 billion.
Outlook and guidance
Raised 2024 guidance: organic net revenue growth forecast at 7.5%–9%, organic operating income growth at 11%–13%, and adjusted diluted EPS growth at 11%–13% excluding currency.
Full-year adjusted diluted EPS expected at $6.33–$6.45, with reported diluted EPS forecasted at $5.89–$6.01.
Q3 adjusted diluted EPS forecasted at $1.77–$1.82.
Full-year operating cash flow expected around $11 billion, with capex of $1.3–$1.4 billion.
HTU shipment volumes expected around 140 billion units for 2024; U.S. nicotine pouch shipments of 560–580 million cans.
Latest events from Philip Morris International
- 2025 EPS guidance targets 13–15% growth, led by robust smoke-free product expansion and margin gains.PM
Barclays 18th Annual Global Consumer Staples Conference 202516 Jul 2026 - Smoke-free products and innovation drive growth, with ZYN and IQOS leading global expansion.PM
Morgan Stanley Global Consumer & Retail Conference 20259 Jul 2026 - Smoke-free product momentum and multi-category strategy drive robust 2025 financial outlook.PM
2025 dbAccess Global Consumer Conference29 Jun 2026 - Smoke-free product momentum and raised EPS guidance highlight strong 2024 growth outlook.PM
21st Annual dbAccess Global Consumer Conference29 Jun 2026 - Smoke-free products drive growth, with ZYN ULTRA and IQOS expanding amid regulatory progress.PM
23rd annual dbAccess Global Consumer Conference2 Jun 2026 - Strong financial and smoke-free growth, dividend increase, and all board proposals but one approved.PM
AGM 20268 May 2026 - Adjusted EPS up 16% to $1.96, with smoke-free products now 43% of revenue, led by IQOS.PM
Q1 202624 Apr 2026 - Smoke-free growth and double-digit EPS gains fuel a strong 2026 outlook and new segment structure.PM
Q4 202521 Apr 2026 - Proxy materials corrected to confirm Werner Geissler as Compensation Committee Chair.PM
Proxy filing31 Mar 2026